Discounted Cash Flow Rating

Buy

Return on Equity Rating

Buy

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Krystal Biotech, Inc. Common Stock (KRYS)

Biological Products, (no Disgnostic Substances)

https://www.krystalbio.com

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.

2100 WHARTON STREET, SUITE 701
PITTSBURGH, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/20/2017

Market Cap

5,559,235,650

Shares Outstanding

28,210,000

Weighted SO

28,206,330

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

MGTX --.--%

APLS --.--%

DCPH --.--%

RGNX --.--%

RYTM --.--%

Beta

0.8360

Last Div

0.0000

Range

93.95-219.34

Chg

-0.4800

Avg Vol

405064

Mkt Cap

5559235650

Exch

NASDAQ

Country

US

Phone

412 586 5830

DCF Diff

164.8897

DCF

29.0903

Div Yield

0.0000

P/S

33.4424

EV Multiple

241.3952

P/FV

6.5964

Div Yield %

0.0000

P/E

52.2349

PEG

0.4869

Payout

0.0000

Current Ratio

9.5026

Quick Ratio

9.3331

Cash Ratio

4.8125

DSO

226.6767

DIO

296.0596

Op Cycle

522.7363

DPO

131.8765

CCC

390.8598

Gross Margin

0.9097

Op Margin

-0.0510

Pretax Margin

0.6520

Net Margin

0.6373

Eff Tax Rate

0.0600

ROA

0.1154

ROE

0.1336

ROCE

-0.0100

NI/EBT

0.9775

EBT/EBIT

-12.7913

EBIT/Rev

-0.0510

Debt Ratio

0.0015

D/E

0.0016

LT Debt/Cap

0.0000

Total Debt/Cap

0.0016

Int Coverage

0.3389

CF/Debt

-12.2983

Equity Multi

1.0939

Rec Turnover

1.6102

Pay Turnover

2.7677

Inv Turnover

1.2329

FA Turnover

1.0046

Asset Turnover

0.1811

OCF/Share

-0.5853

FCF/Share

-0.7958

Cash/Share

19.5682

OCF/Sales

-0.1007

FCF/OCF

1.3596

CF Coverage

-12.2983

ST Coverage

-12.2983

CapEx Coverage

-2.7809

Div&CapEx Cov

-2.7809

P/BV

6.5964

P/B

6.5964

P/S

33.4424

P/E

52.2349

P/FCF

-244.2868

P/OCF

-330.6078

P/CF

-330.6078

PEG

0.4869

P/S

33.4424

EV Multiple

241.3952

P/FV

6.5964

DPS

0.0000

Latest Headlines (EST)

Benzinga Dec 13, 13:00 Expert Ratings for Krystal Biotech The Motley Fool Nov 10, 06:55 This Stock Has Quadrupled in 5 Years. Can It Do It Again? Benzinga Oct 24, 11:00 Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023

Revenue Product Segmentation

a